Medical Condition News

RSS

Melanin also protects from ionizing radiation

Sunbathers have long known that melanin in their skin cells provides protection from the damage caused by visible and ultraviolet light. More recent studies have shown that melanin, which is produced by multitudes of the planet's life forms, also gives some species protection from ionizing radiation. In certain microbes, in particular some organisms from near the former nuclear reactor facilities in Chernobyl, melanin has even been linked to increased growth in the presence of ionizing radiation.

24 Aug 2011

Mylan subsidiary to exclusively offer EpiPen 2-Pak and EpiPen Jr 2-Pak Auto-Injector

Dey Pharma, L.P., a subsidiary of Mylan Inc., today announced that Dey will exclusively offer the EpiPen 2-Pak and EpiPen Jr 2-Pak (epinephrine) Auto-Injector 0.3/0.15 mg, to encourage physicians and patients to follow recommendations by the National Institute of Allergy and Infectious Diseases (NIAID).

24 Aug 2011

KFDA approves IND for DP-b99 Phase III MACSI stroke study in Korea

D-Pharm Ltd., announced today that the Korean Food & Drug Administration (KFDA) approved the Investigational New Drug application for the Phase III MACSI study of DP-b99 in Korea. The IND has been submitted by D-Pharm's co-development partner in South Korea, Yungjin Pharmaceutical Company Ltd..

24 Aug 2011

Major new guideline on treatment of high blood pressure

The way blood pressure is diagnosed and treated is set to be revolutionised following new guidelines for the medical profession issued by NICE and developed in conjunction with the British Hypertension Society (BHS).

24 Aug 2011

A pain-free way of tackling dental decay

Researchers at the University of Leeds have discovered a pain-free way of tackling dental decay that reverses the damage of acid attack and re-builds teeth as new.

24 Aug 2011

Sarcoma Oncology Center, Aethlon Medical to study ex vivo effectiveness of Hemopurifier

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it has entered into an agreement with the Sarcoma Oncology Center to study the ex vivo effectiveness of the Aethlon Hemopurifier to remove immunosuppressive exosomes from the blood of advanced-stage cancer patients.

24 Aug 2011

Kibow renews exclusive worldwide veterinary licensing and marketing agreement

Kibow Biotech, Inc. today announced that it has renewed its exclusive worldwide licensing and marketing agreement with the current licensing partner specializing in animal health.

24 Aug 2011

Scientists aim to tackle Hawaii's liver cancer problem with improved detection

Two scientists from the University of Hawaii Cancer Center and The Queen's Medical Center have received a five-year $2.3 million grant from the National Cancer Institute to develop novel methods that can better detect liver cancer through the joint analysis of gene expression and imaging data of the liver.

24 Aug 2011

Streamlining esophagectomy reduces hospital stay, cost associated with surgery

Thoracic surgeons at University of Iowa Hospitals and Clinics have found that by altering the pre- and post-surgical care of a patient in need of an esophagectomy they are able to reduce the length of hospital stay by more than two-thirds and have a significant impact on the overall costs.

24 Aug 2011

U.S. DoD announces $2.3M in grants for lupus research

The Lupus Foundation of America (LFA) congratulates Trine Jorgensen, Ph.D., Assistant Staff, Department of Immunology, Cleveland Clinic Foundation and I-Cheng Ho, M.D., Ph.D., Associate Physician, Brigham and Women's Hospital, for being selected to receive research grants totaling $2.3 million from the U.S. Department of Defense's (DoD) Congressionally Directed Peer Reviewed Medical Research Program.

24 Aug 2011

United Therapeutics completes treprostinil diethanolamine Phase 3 trial in PAH

United Therapeutics Corporation announced today the completion of its FREEDOM-C(2) Phase 3 trial of treprostinil diethanolamine, an investigational sustained release oral formulation of treprostinil, a stable synthetic form of prostacyclin, in patients with pulmonary arterial hypertension.

24 Aug 2011

Health Quest Systems selects RayStation for advanced treatments

RaySearch Laboratories AB has received an order for its RayStation treatment planning system from Health Quest Systems, Inc., headquartered in LaGrange, New York.

24 Aug 2011

People admitted to hospital for mental illness more likely to experience control intervention

The use of control interventions, including physical and mechanical restraints, acute control medications and seclusion, is intended to be a method of last resort in Ontario care facilities, including hospitals.

24 Aug 2011

$New invasive procedures may help patients with chronic refractory headache$

New invasive procedures may help patients with chronic refractory headache

Cluster headache has a substantial detrimental effect on quality of life. New invasive procedures, such as hypothalamic deep brain stimulation and bilateral occipital nerve stimulation, may help patients with chronic refractory headache.

24 Aug 2011

IGF1 plays key role in T-cell acute lymphoblastic leukemia

There are numerous specialized growth factors that are responsible for cells of different tissues of our body to divide and differentiate when needed. These hormone-like factors bind to matching receptors on the surface of their target cells and thus give order for the cell to divide. However, a single genetic alteration can be sufficient for the whole system to get out of control.

24 Aug 2011

Avastin increases tumor response rates in breast cancer patients before surgery

Amid the controversy surrounding the Food and Drug Administration's ruling that Avastin should no longer be used to treat metastatic breast cancer, a new multinational Phase III clinical trial shows that Avastin significantly increased tumor response rates in breast cancer patients when given before surgery.

24 Aug 2011

Creighton University receives NIH grant to address diabetes in adult American Indians

Creighton University School of Nursing has received a $207,000, two-year grant from the National Institutes of Health to address the growing problem of type 2 diabetes mellitus in adult American Indians.

24 Aug 2011

New Pressurized Olfactory Device shows direct CNS effect of morphine

A simple new approach to nasal drug administration may allow morphine and other strong pain medications to be targeted directly to the central nervous system (CNS), reports an experimental study in the September issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

24 Aug 2011

IARS launches $750,000 anesthesia research grant

The International Anesthesia Research Society (IARS) launched a $750,000 research grant today - the largest single grant offered by the Society in its 90 year history. The Frontiers in Anesthesia Research Award, created in 1995, has traditionally been a $500,000 grant.

24 Aug 2011

Clay modelling could help disturbed teenagers deal with mental health problems

Researchers at The University of Nottingham are to investigate whether the therapeutic effects of clay modelling could help disturbed teenagers deal with their feelings of anger, anxiety and depression.

24 Aug 2011